Older Men and Testosterone

Plain-language summary

This study examines the effects of Nebido (Testosterone Undecanoate) in older men with low testosterone levels. It enrolled men aged 60 to 80 with low blood testosterone levels. The research was conducted as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

University Hospital of North Norway

Intervention

Nebido (Testosterone Undecanoate)

Start date

9/1/2005

Estimated completion

12/1/2007

Countries

Norway

Related genes

Locations

• Tromsø, Norway

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Men 60-80 years old
* Serum-testosterone levels \<11.0 nmol/l
* Signed informed consent.

Exclusion Criteria:

* Prostate cancer
* Breast cancer
* Liver tumor/cancer
* Unstable angina
* Untreated congestive heart disease
* Epilepsy
* Migraine
* Hematocrit \>50%
* PSA \>4.0 ug/l
* Serum creatinine \>130 umol/l
* ALAT \>100 U/l
* Known intolerance to testosterone undecanoate
* Participation in another research trial.